Comparación de estrategias de navegación colaborativa para robótica móvil

En el presente trabajo se comparan dos estrategias de navegación colaborativas, enmarcadas en el contexto de grupos de múltiples robots móviles, aplicados a la búsqueda de rutas óptimas entre un punto de partida y un punto de destino cuya ubicación es desconocida. Se describen las tendencias de la robótica móvil colaborativa y los enfoques de Inteligencia Artificial aplicados, haciendo énfasis en los sistemas de múltiples agentes y las metaheurísticas comúnmente usadas en este ámbito. Posteriormente se hace un análisis de las arquitecturas y se propone una arquitectura inspirada en un sistema nervioso biológico. Finalmente se hace un estudio estadístico que contrasta una estrategia tipo enjambre con una estrategia tipo multiagente, a partir de simulaciones de sistemas multi-robot, con el fin de determinar cuál de estas presenta mejor desempeño para ejecución de tareas colectivas, en ambientes simulados aplicadas a sistemas multi-robots.In the present work, two collaborative navigation strategies are compared, framed in the context of groups of multiple mobile robots, applied to the search for optimal routes between a starting point and a destination point whose location is unknown. The trends in collaborative mobile robotics and applied Artificial Intelligence approaches are described, with an emphasis on multi-agent systems and metaheuristics commonly used in this area. Subsequently, an analysis of the architectures is made and an architecture inspired by a biological nervous system is proposed. Finally, a statistical study is carried out that contrasts a swarm-type strategy with a multi-agent type strategy, based on simulations of multi-robot systems, in order to determine which of these presents better performance for the execution of collective tasks, in simulated environments applied to multi-robot systems

Chronological and biological aging of the human left ventricular myocardium: Analysis of microRNAs contribution

Aging is the main risk factor for cardiovascular diseases. In humans, cardiac aging remains poorly characterized. Most studies are based on chronological age (CA) and disregard biological age (BA), the actual physiological age (result of the aging rate on the organ structure and function), thus yielding potentially imperfect outcomes. Deciphering the molecular basis of ventricular aging, especially by BA, could lead to major progresses in cardiac research. We aim to describe the transcriptome dynamics of the aging left ventricle (LV) in humans according to both CA and BA and characterize the contribution of microRNAs, key transcriptional regulators. BA is measured using two CA-associated transcriptional markers: CDKN2A expression, a cell senescence marker, and apparent age (AppAge), a highly complex transcriptional index. Bioinformatics analysis of 132 LV samples shows that CDKN2A expression and AppAge represent transcriptomic changes better than CA. Both BA markers are biologically validated in relation to an aging phenotype associated with heart dysfunction, the amount of cardiac fibrosis. BA-based analyses uncover depleted cardiac-specific processes, among other relevant functions, that are undetected by CA. Twenty BA-related microRNAs are identified, and two of them highly heart-enriched that are present in plasma. We describe a microRNA-gene regulatory network related to cardiac processes that are partially validated in vitro and in LV samples from living donors. We prove the higher sensitivity of BA over CA to explain transcriptomic changes in the aging myocardium and report novel molecular insights into human LV biological aging. Our results can find application in future therapeutic and biomarker research

Maritime-oriented foragers during the Late Pleistocene on the eastern costa del sol (Southeast Iberia): Cueva Victoria (Málaga, Spain)

The Mediterranean coast of Spain is marked by several clusters of Palaeolithic sites: to the south of the Pyrenees, in the area around the Ebro River, in the central part, and on the south coast, one of the southernmost regions in Europe. The number of sites is small compared with northern Iberia, but like that region, the Palaeolithic occupations are accompanied by several rock art ensembles. The archaeological material (both biotic and abiotic resources) and radiocarbon dates presented here were obtained during archaeological fieldwork of professor J. Fortea in the Late Pleistocene deposits in Cueva Victoria, located near the modern coastline and about 150 km north of the Strait of Gibraltar. In the three occupation phases, marine resources were acquired by shell-fishing (focusing almost exclusively on the clam Ruditapes decussatus), fishing, and the use of beached marine mammals. This contrasts with the limited data about the exploitation of terrestrial resources by hunting and gathering animals and plants. The study is completed by the study of artefacts (lithic and bone industry and objects of adornment) that help to understand the subsistence strategies of the cave occupants and enable a comparison with other groups inhabiting the Mediterranean coasts of the Iberian Peninsula during Greenland Interstadial 1, between ca. 15.1 and 13.6 cal BP.This work was supported by the University of Salamanca GIR PREHUSAL, the Ministry of Science and Innovation-Spanish Government (PaleontheMove-PID2020-114462GB-I00), the Universidad Nacional de Educación a Distancia (Madrid) and Dirección General de Universitat, Investigacio i Ciencia of the Valencian Regional Government (Project Aico/2020/97).Peer reviewe

Evaluación de la seguridad de productos cosméticos

ilustracionesLa Organización de las Naciones Unidas para el Desarrollo Industrial (onudi), a través del programa Safe+, coordinó varias estrategias de cooperación internacional para apoyar el crecimiento de la industria cosmética colombiana, entre ellas la capacitación en evaluación de la seguridad de productos cosméticos. En este contexto, en 2018, una de las acciones que emprendió la Universidad Nacional de Colombia, fue ofertar el Curso de Formación de Consultores en Evaluación de Seguridad de Productos Cosméticos, a través del Departamento de Farmacia de la Facultad de Ciencias, con la asesoría y el diseño del consultor internacional Dr. Philippe Masson. En 2022, esta capacitación fue ampliada en número de horas impartidas, lo que permitió realizar el Diplomado en Evaluación de la Seguridad de Productos Cosméticos (Safety Assessor Training), en la modalidad telepresencial, el cual contó con la participación de más de 30 expertos. Este documento presenta los resúmenes de 53 conferencias, que hicieron parte de seis módulos: 1) contexto regulatorio de las materias primas y cosméticos; 2) aspectos de seguridad relacionados con ingredientes y productos cosméticos; 3) fundamentos de fisiología, inmunología y toxicología; 4) herramientas de evaluación toxicológica; 5) gestión del riesgo y gestión documental en la evaluación de seguridad de cosméticos; y 6) asuntos de interés en la actualidad. Esperamos con este diplomado contribuir con los fines misionales de la Universidad Nacional de Colombia, a través de la educación continua y permanente con carácter científico y tecnológico dirigida a profesionales de la industria cosmética. (Texto tomado de la fuente)Introducción -- Importancia de la formación en evaluación de seguridad para el sector cosmético -- Evaluación de calidad de productos cosméticos: introducción -- Bibliografía recomendadaMódulo 1. Contexto regulatorio de las materias primas y cosméticos -- Situación normativa en Latinoamérica con relación a la seguridad de cosméticos -- Legislación de cosméticos en la Comunidad Andina de Naciones (can) y su influencia en Colombia -- Referencias regulatorias con relación a la seguridad de cosméticos: Unión Europea y Estados Unidos -- Referencias regulatorias con relación a la seguridad de cosméticos: Asia -- Normas técnicas internacionales en seguridad de productos cosméticos -- Bibliografía recomendadaMódulo 2: aspectos de seguridad relacionados con ingredientes y productos cosméticos -- Seguridad de productos cosméticos – Quality by Design -- Origen de los ingredientes cosméticos -- Ingredientes cosméticos obtenidos por síntesis química -- Ingredientes cosméticos de origen natural -- Ingredientes cosméticos de origen biológico y biotecnológico -- Disposiciones particulares relativas a las fragancias -- Clasificación de ingredientes cosméticos y restricciones -- Estabilidad a lo largo del ciclo de vida del producto -- Estabilidad fisicoquímica -- Estabilidad microbiológica -- Envase seguro: ingeniería de envases -- Envase seguro: extractables y lixiviados de envases -- Bibliografía recomendadaMódulo 3. Fundamentos de fisiología, inmunología y toxicología -- Fundamentos: sistema inmune y piel -- Fundamentos: piel y mucosas, organización y funciones -- Evolución de la piel con la edad -- Irritación cutánea, ocular y mucosas -- Alergenicidad y sensibilización cutánea -- Fotosensibilidad cutánea y fotoirritación -- Conceptos generales en toxicología: evaluación del riesgo toxicológico -- Penetración y absorción percutánea -- Toxicidad general por vía oral y tópica -- Toxicidad de la reproducción -- Genotoxicidad, mutagenicidad y cáncer -- Bibliografía recomendadaMódulo 4. Herramientas de evaluación toxicológica -- Métodos experimentales in vivo y sus límites -- Metodologías in vitro para la evaluación de seguridad de ingredientes cosméticos -- Métodos in vitro. Experiencias en el laboratorio -- Evaluación de la penetración cutánea -- Métodos in silico como fuentes adicionales de información -- Estudios clínicos para la evaluación de cosméticos -- Cálculo del margen de seguridad -- Umbral de preocupación toxicológica (ttc) -- Bibliografía recomendadaMódulo 5. Gestión del riesgo y gestión documental en la evaluación de la seguridad de cosméticos -- Buenas prácticas de laboratorio -- Calidad de los datos experimentales -- Dossier, pif o expediente de información de producto -- Gestión del riesgo -- Caracterización y gestión del riesgo -- Acceso a los datos de ingredientes cosméticos a través de los comités científicos sccs, cir -- Claims / proclamas -- Claims vs. Soportes -- Bibliografía recomendadaMódulo 6. Asuntos de interés en la actualidad -- Uso de nanomateriales en productos cosméticos: ¿es un riesgo? -- Disrupción endocrina -- Impacto de los cosméticos en el ambiente – Cosmetovigilancia -- Pieles sensibles: consideraciones generales y aspectos reglamentarios -- Ética y estudios de seguridad -- Nuevas aproximaciones metodológicas (nam) -- Bibliografía recomendad

Latin American study of hereditary breast and ovarian cancer LACAM : a genomic epidemiology approach

Q2Q1Artículo original1-13Purpose: Hereditary Breast and Ovarian Cancer (HBOC) syndrome is responsible for ~5–10% of all diagnosed breast and ovarian cancers. Breast cancer is the most common malignancy and the leading cause of cancer-related mortality among women in Latin America (LA). The main objective of this study was to develop a comprehensive understanding of the genomic epidemiology of HBOC throughout the establishment of The Latin American consortium for HBOC-LACAM, consisting of specialists from 5 countries in LA and the description of the genomic results from the first phase of the study. Methods: We have recruited 403 individuals that fulfilled the criteria for HBOC from 11 health institutions of Argentina, Colombia, Guatemala, Mexico and Peru. A pilot cohort of 222 individuals was analyzed by NGS gene panels. One hundred forty-three genes were selected on the basis of their putative role in susceptibility to different hereditary cancers. Libraries were sequenced in MiSeq (Illumina, Inc.) and PGM (Ion Torrent-Thermo Fisher Scientific) platforms. Results: The overall prevalence of pathogenic variants was 17% (38/222); the distribution spanned 14 genes and varied by country. The highest relative prevalence of pathogenic variants was found in patients from Argentina (25%, 14/57), followed by Mexico (18%, 12/68), Guatemala (16%, 3/19), and Colombia (13%, 10/78). Pathogenic variants were found in BRCA1 (20%) and BRCA2 (29%) genes. Pathogenic variants were found in other 12 genes, including high and moderate risk genes such as MSH2, MSH6, MUTYH, and PALB2. Additional pathogenic variants were found in HBOC unrelated genes such as DCLRE1C, WRN, PDE11A, and PDGFB. Conclusion: In this first phase of the project, we recruited 403 individuals and evaluated the germline genetic alterations in an initial cohort of 222 patients among 4 countries. Our data show for the first time in LA the distribution of pathogenic variants in a broad set of cancer susceptibility genes in HBOC. Even though we used extended gene panels, there was still a high proportion of patients without any detectable pathogenic variant, which emphasizes the larger, unexplored genetic nature of the disease in these populations

Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study

Background: Approximately 450 000 children are born with familial hypercholesterolaemia worldwide every year, yet only 2·1% of adults with familial hypercholesterolaemia were diagnosed before age 18 years via current diagnostic approaches, which are derived from observations in adults. We aimed to characterise children and adolescents with heterozygous familial hypercholesterolaemia (HeFH) and understand current approaches to the identification and management of familial hypercholesterolaemia to inform future public health strategies. Methods: For this cross-sectional study, we assessed children and adolescents younger than 18 years with a clinical or genetic diagnosis of HeFH at the time of entry into the Familial Hypercholesterolaemia Studies Collaboration (FHSC) registry between Oct 1, 2015, and Jan 31, 2021. Data in the registry were collected from 55 regional or national registries in 48 countries. Diagnoses relying on self-reported history of familial hypercholesterolaemia and suspected secondary hypercholesterolaemia were excluded from the registry; people with untreated LDL cholesterol (LDL-C) of at least 13·0 mmol/L were excluded from this study. Data were assessed overall and by WHO region, World Bank country income status, age, diagnostic criteria, and index-case status. The main outcome of this study was to assess current identification and management of children and adolescents with familial hypercholesterolaemia. Findings: Of 63 093 individuals in the FHSC registry, 11 848 (18·8%) were children or adolescents younger than 18 years with HeFH and were included in this study; 5756 (50·2%) of 11 476 included individuals were female and 5720 (49·8%) were male. Sex data were missing for 372 (3·1%) of 11 848 individuals. Median age at registry entry was 9·6 years (IQR 5·8-13·2). 10 099 (89·9%) of 11 235 included individuals had a final genetically confirmed diagnosis of familial hypercholesterolaemia and 1136 (10·1%) had a clinical diagnosis. Genetically confirmed diagnosis data or clinical diagnosis data were missing for 613 (5·2%) of 11 848 individuals. Genetic diagnosis was more common in children and adolescents from high-income countries (9427 [92·4%] of 10 202) than in children and adolescents from non-high-income countries (199 [48·0%] of 415). 3414 (31·6%) of 10 804 children or adolescents were index cases. Familial-hypercholesterolaemia-related physical signs, cardiovascular risk factors, and cardiovascular disease were uncommon, but were more common in non-high-income countries. 7557 (72·4%) of 10 428 included children or adolescents were not taking lipid-lowering medication (LLM) and had a median LDL-C of 5·00 mmol/L (IQR 4·05-6·08). Compared with genetic diagnosis, the use of unadapted clinical criteria intended for use in adults and reliant on more extreme phenotypes could result in 50-75% of children and adolescents with familial hypercholesterolaemia not being identified. Interpretation: Clinical characteristics observed in adults with familial hypercholesterolaemia are uncommon in children and adolescents with familial hypercholesterolaemia, hence detection in this age group relies on measurement of LDL-C and genetic confirmation. Where genetic testing is unavailable, increased availability and use of LDL-C measurements in the first few years of life could help reduce the current gap between prevalence and detection, enabling increased use of combination LLM to reach recommended LDL-C targets early in life

Impact of COVID-19 on cardiovascular testing in the United States versus the rest of the world

Objectives: This study sought to quantify and compare the decline in volumes of cardiovascular procedures between the United States and non-US institutions during the early phase of the coronavirus disease-2019 (COVID-19) pandemic. Background: The COVID-19 pandemic has disrupted the care of many non-COVID-19 illnesses. Reductions in diagnostic cardiovascular testing around the world have led to concerns over the implications of reduced testing for cardiovascular disease (CVD) morbidity and mortality. Methods: Data were submitted to the INCAPS-COVID (International Atomic Energy Agency Non-Invasive Cardiology Protocols Study of COVID-19), a multinational registry comprising 909 institutions in 108 countries (including 155 facilities in 40 U.S. states), assessing the impact of the COVID-19 pandemic on volumes of diagnostic cardiovascular procedures. Data were obtained for April 2020 and compared with volumes of baseline procedures from March 2019. We compared laboratory characteristics, practices, and procedure volumes between U.S. and non-U.S. facilities and between U.S. geographic regions and identified factors associated with volume reduction in the United States. Results: Reductions in the volumes of procedures in the United States were similar to those in non-U.S. facilities (68% vs. 63%, respectively; p = 0.237), although U.S. facilities reported greater reductions in invasive coronary angiography (69% vs. 53%, respectively; p < 0.001). Significantly more U.S. facilities reported increased use of telehealth and patient screening measures than non-U.S. facilities, such as temperature checks, symptom screenings, and COVID-19 testing. Reductions in volumes of procedures differed between U.S. regions, with larger declines observed in the Northeast (76%) and Midwest (74%) than in the South (62%) and West (44%). Prevalence of COVID-19, staff redeployments, outpatient centers, and urban centers were associated with greater reductions in volume in U.S. facilities in a multivariable analysis. Conclusions: We observed marked reductions in U.S. cardiovascular testing in the early phase of the pandemic and significant variability between U.S. regions. The association between reductions of volumes and COVID-19 prevalence in the United States highlighted the need for proactive efforts to maintain access to cardiovascular testing in areas most affected by outbreaks of COVID-19 infection

Diagnóstico del proceso de comunicación en la estrategia de promoción del sector cultural y deportivo de la Pontificia Universidad Javeriana-seccional Cali

Tesis (Comunicador Social-Periodista)--Corporación Universitaria Autónoma de Occidente. División de comunicación social-periodismo, 1997PregradoComunicador(a) Social – Periodist

Fundamentos y principios de la educación especial : aspectos didácticos y organizativos

La labor del experto de la educación especial pasa por dinamizar los procesos educativos dentro del centro escolar. Se ha de facilitar la inclusión del alumnado de necesidades específicas de apoyo educativo e involucrar al conjunto de la comunidad educativa en el proceso de cambio, en la toma de decisiones y el trabajo compartido con este alumnado. Se pretende profundizar en el conocimiento de la educación especial y la legislación. Se divide en cinco bloques: aspectos introductorios y teóricos; aspectos organizativos de la Educación Especial; aspectos didácticos de la Educación Especial; programas y recursos para la atención a la diversidad; y asesoramiento y orientación a la comunidad educativa.MadridBiblioteca de Educación del Ministerio de Educación, Cultura y Deporte; Calle San Agustín 5 -3 Planta; 28014 Madrid; Tel. +34917748000; [email protected]